204 related articles for article (PubMed ID: 22663293)
1. Can CER be an effective tool for change in the development and assessment of new drugs and technologies?
Brixner DI; Watkins JB
J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S06-11. PubMed ID: 22663293
[TBL] [Abstract][Full Text] [Related]
2. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
[TBL] [Abstract][Full Text] [Related]
3. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
Mullins CD; Sanchez RJ
J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Implementing CER: what will it take?
Biskupiak JE; Dunn JD; Holtorf AP
J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S19-29. PubMed ID: 22663296
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Bringing liraglutide to market: a CER case study.
Oderda G; Sifford-Wilson SM
J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S12-8. PubMed ID: 22663295
[TBL] [Abstract][Full Text] [Related]
8. Impact of Postapproval Evidence Generation on the Biopharmaceutical Industry.
Milne CP; Cohen JP; Felix A; Chakravarthy R
Clin Ther; 2015 Aug; 37(8):1852-8. PubMed ID: 26143223
[TBL] [Abstract][Full Text] [Related]
9. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
Oderda GM; Balfe LM
J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
[TBL] [Abstract][Full Text] [Related]
11. The pragmatist's guide to comparative effectiveness research.
Chandra A; Jena AB; Skinner JS
J Econ Perspect; 2011; 25(2):27-46. PubMed ID: 21595324
[TBL] [Abstract][Full Text] [Related]
12. AMCP Partnership Forum: Enabling the Exchange of Clinical and Economic Information Pre-FDA Approval.
J Manag Care Spec Pharm; 2017 Jan; 23(1):105-112. PubMed ID: 28025919
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness and cost-effectiveness analyses frequently agree on value.
Glick HA; McElligott S; Pauly MV; Willke RJ; Bergquist H; Doshi J; Fleisher LA; Kinosian B; Perfetto E; Polsky DE; Schwartz JS
Health Aff (Millwood); 2015 May; 34(5):805-11. PubMed ID: 25941282
[TBL] [Abstract][Full Text] [Related]
14. A call for action: Comparative effectiveness research in asthma.
Krishnan JA; Schatz M; Apter AJ
J Allergy Clin Immunol; 2011 Jan; 127(1):123-7. PubMed ID: 20855111
[TBL] [Abstract][Full Text] [Related]
15. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
16. PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH.
Moloney R; Mohr P; Hawe E; Shah K; Garau M; Towse A
Int J Technol Assess Health Care; 2015 Jan; 31(1-2):90-8. PubMed ID: 26168804
[TBL] [Abstract][Full Text] [Related]
17. Methods for the comparative evaluation of pharmaceuticals.
Zentner A; Velasco-Garrido M; Busse R
GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
[TBL] [Abstract][Full Text] [Related]
18. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
